{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:49:00Z","timestamp":1791978540825,"version":"4.4.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clinthera.2023.07.026","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T15:25:29Z","timestamp":1693236329000},"page":"1259-1265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity"],"prefix":"10.1016","volume":"45","author":[{"given":"Matthew","family":"Anson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sizheng Steven","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Essa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema Hern\u00e1ndez","family":"Ibarburu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2023.07.026_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0002","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00125-022-05713-6","article-title":"Low- and middle-income countries demonstrate rapid growth of type 2 diabetes: an analysis based on Global Burden of Disease 1990\u20132019 data","volume":"65","author":"Liu","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0003","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000599","article-title":"Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Aikaeli","year":"2022","journal-title":"PLOS Global Public Health"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0004","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/dc17-1144","article-title":"The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study)","volume":"42","author":"Laiteerapong","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0005","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1007\/s00125-021-05539-8","article-title":"The legacy effect in diabetes: are there long-term benefits?","volume":"64","author":"Folz","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0006","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0007","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Collaborative Group","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0008","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","article-title":"Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes","volume":"372","author":"Hayward","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0009","unstructured":"NHS digital. National Diabetes Audit, 2020-21 Report 1: Care Processes and Treatment Targets. 2022. Available at: https:\/\/digital.nhs.uk\/data-and-information\/publications\/statistical\/national-diabetes-audit\/core-report-1-2020-21. Accessed March 24, 2023,"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0010","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1007\/s11606-019-05587-2","article-title":"Trends in diabetes management among US adults: 1999-2016","volume":"35","author":"Fang","year":"2020","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0011","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011295","article-title":"Diabetes mellitus\u2013related all-cause and cardiovascular mortality in a national cohort of adults","volume":"8","author":"Raghavan","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.00518","article-title":"The challenges in the development of diabetes prevention and care models in low-income settings","volume":"11","author":"Karachaliou","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155217","article-title":"A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on","volume":"133","author":"Boutari","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0014","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2147\/CLEP.S227621","article-title":"Ethnic differences in the prevalence of type 2 diabetes diagnoses in the UK: cross-sectional analysis of the Health Improvement Network Primary Care Database","volume":"11","author":"Pham","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17030950","article-title":"Racial\/ethnic differences in glycemic control in older adults with type 2 diabetes: United States 2003-2014","volume":"17","author":"Smalls","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0016","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11892-020-01369-x","article-title":"Diabetes complications in racial and ethnic minority populations in the USA","volume":"21","author":"Haw","year":"2021","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0017","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171315","article-title":"Effect of ethnicity on HbA1c levels in individuals without diabetes: systematic review and meta-analysis","volume":"12","author":"Cavagnolli","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0018","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0019","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/HPC.0b013e318053da59","article-title":"The management of hypertension in African Americans","volume":"6","author":"Ferdinand","year":"2007","journal-title":"Crit Pathw Cardiol"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0020","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in Blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0021","doi-asserted-by":"crossref","first-page":"813","DOI":"10.7326\/M20-2470","article-title":"Pharmacologic approaches to glycemic treatment of type 2 diabetes: synopsis of the 2020 American Diabetes Association's Standards of Medical Care in Diabetes Clinical Guideline","volume":"173","author":"Doyle-Delgado","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0022","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/jcm11061470","article-title":"SGLT2 inhibitors in type 2 diabetes mellitus and heart failure\u2014a concise review","volume":"11","author":"Keller","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0023","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","article-title":"Modern-day clinical course of type 1 diabetes mellitus after 30 years\u2019 duration","volume":"169","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0024","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/9927533","article-title":"The role of SGLT2 inhibitors in heart failure: a systematic review and meta-analysis","volume":"2021","author":"Tsampasian","year":"2021","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0026","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/jama.2022.13885","article-title":"Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration System","volume":"328","author":"Lamprea-Montealegre","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0027","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2023.07.026_bib0028","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1741-7015-11-141","article-title":"Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and \u03b2-adrenergic blockers? A systematic review","volume":"11","author":"Brewster","year":"2013","journal-title":"BMC Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291823003028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:59:32Z","timestamp":1758963572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291823003028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0149291823003028"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.07.026","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin and SGLT2i as First-line Combination Therapy in Type 2 Diabetes: A Real-world Study With a Focus on Ethnicity","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2023.07.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}